Plain-English translation of NCT06339424 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a combination approach to treating advanced liver cancer. Researchers want to see if giving and together with radiation therapy works better than the medications alone. The two drugs help your immune system fight cancer, and the radiation targets the tumor directly—doctors hope using all three together will create a stronger effect against the cancer.
Currently, this medication combination helps some patients, but many still experience cancer growth or liver failure. Scientists have discovered in laboratory studies that adding radiation therapy might help the immune system respond more powerfully to cancer, but this combination hasn't been properly tested in real patients with liver cancer yet.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive the two immunotherapy medications by infusion and undergo radiation therapy sessions focused on your liver tumor. The study will monitor how well the treatment works, check for side effects, and measure changes in your immune system through blood tests. You'll have regular appointments with the research team to assess your response and overall health throughout the treatment period.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
Taiwan